Individualization of dose and fractionation of radiotherapy for head and neck cancers

被引:0
作者
Blanchard, P. [1 ,2 ,3 ]
Biau, J. [4 ,5 ,6 ]
Castelli, J. [7 ,8 ,9 ]
Tao, Y. [1 ]
Graff, P. [10 ]
Nguyen, F. [1 ]
机构
[1] Gustave Roussy, Dept Radiotherapie Oncol, Canc Campus,114 Rue Edouard Vaillant, F-94800 Villejuif, France
[2] CESP, INSERM, U1018, F-94800 Villejuif, France
[3] Univ Paris Saclay, F-94800 Villejuif, France
[4] Ctr Jean Perrin, Dept Radiotherapie Oncol, F-63000 Clermont Ferrand, France
[5] Univ Clermont Auvergne, F-63000 Clermont Ferrand, France
[6] INSERM, Imagerie Mol & Strat Theranost U1240, F-63000 Clermont Ferrand, France
[7] Ctr Eugene Marquis, Dept Radiotherapie, F-35000 Rennes, France
[8] INSERM, LTSI U1099, F-35000 Rennes, France
[9] Univ Rennes 1, F-35000 Rennes, France
[10] IUCT Oncopole, Dept Radiotherapie, F-31000 Toulouse, France
来源
CANCER RADIOTHERAPIE | 2019年 / 23卷 / 6-7期
关键词
Head and neck cancer; Nasopharyngeal cancer; Chemotherapy; Epstein-Barr virus; Meta-analysis; Radiotherapy; Fractionation; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TARGET VOLUMES CTV; HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CONVENTIONAL RADIOTHERAPY; OROPHARYNGEAL CANCER; RADIATION-THERAPY; QUALITY-ASSURANCE; DE-ESCALATION;
D O I
10.1016/j.canrad.2019.07.131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed. (C) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:784 / 788
页数:5
相关论文
共 50 条
  • [21] Clinicopathology and Treatment Patterns of Head and Neck Cancers in Ethiopia
    Fekadu, Adugna
    Rick, Tara J.
    Tigeneh, Wondemagegnhu
    Kantelhardt, Eva Johanna
    Incrocci, Luca
    Jemal, Ahmedin
    JCO GLOBAL ONCOLOGY, 2022, 8 : e2200073
  • [22] Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis
    Szturz, Petr
    Wouters, Kristien
    Kiyota, Naomi
    Tahara, Makoto
    Prabhash, Kumar
    Noronha, Vanita
    Adelstein, David
    Vermorken, Jan B.
    ORAL ONCOLOGY, 2018, 76 : 52 - 60
  • [23] Intensity modulated radiotherapy for head and neck cancers: Ethics and patients selection
    Renard-Oldrini, S.
    Zielinski, A.
    Mecellem, H.
    Graff, P.
    Marchesi, V.
    Peiffert, D.
    CANCER RADIOTHERAPIE, 2013, 17 (01): : 1 - 9
  • [24] Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup
    Tao, Yungan
    Vintonenko, Nadejeda
    Garcia, Robin
    Marchesi, Vincent
    Tomsej, Milan
    Bardet, Etienne
    Bourhis, Jean
    BULLETIN DU CANCER, 2014, 101 (05) : 481 - 485
  • [25] Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers
    Warwas, Britta
    Cremers, Florian
    Gerull, Karsten
    Leichtle, Anke
    Bruchhage, Karl L.
    Hakim, Samer G.
    Schild, Steven E.
    Rades, Dirk
    ANTICANCER RESEARCH, 2022, 42 (05) : 2657 - 2663
  • [26] PET/CT in radiotherapy planning in head and neck cancers
    Vicente, A. M. Garcia
    Castrejon, A. Soriano
    Londono, G. Andres Jimenez
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (05): : 465 - 470
  • [27] Magnetic Resonance Guided Radiotherapy for Head and Neck Cancers
    Gharzai, Laila A.
    Rosen, Benjamin S.
    Mittal, Bharat
    Mierzwa, Michelle L.
    Yadav, Poonam
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [28] Radiotherapy and Systemic Therapies: Focus on Head and Neck Cancer
    De Felice, Francesca
    Cattaneo, Carlo Guglielmo
    Franco, Pierfrancesco
    CANCERS, 2023, 15 (17)
  • [29] De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond
    Ruehle, Alexander
    Grosu, Anca-Ligia
    Nicolay, Nils H.
    CANCERS, 2021, 13 (09)
  • [30] Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis
    Liu, Yingyu
    Kou, Changgui
    Bai, Wei
    Liu, Xinyu
    Song, Yan
    Zhang, Lili
    Wang, Mohan
    Zhang, Yangyu
    You, Yueyue
    Yin, Yue
    Jiang, Xin
    Xin, Ying
    ONCOTARGETS AND THERAPY, 2018, 11 : 5465 - 5483